Simone Miyasato

Simone Miyasato serves as a key procurement professional within the Great Plains Area Indian Health Service, supporting the agency’s mission to deliver culturally competent, sustainable healthcare to American Indian and Alaska Native communities. Responsible for managing acquisitions that enhance clinical capacity and operational resilience in remote facilities, Miyasato specializes in procuring diagnostic imaging equipment, analytical laboratory instruments, and related healthcare infrastructure. Their work directly supports the agency’s priorities in modernizing medical technology, strengthening IT systems, and ensuring continuity of care in underserved regions, aligning procurement strategy with tribal health outcomes and federal health equity goals. Miyasato maintains consistent working relationships with a core group of specialized vendors, including DT-TRAK CONSULTING, INC., ANDERS GROUP LLC, WAREBROOK HEALTH, LLC, LACREEK DEVELOPMENT CORP, and METRO MEDICAL EQUIPMENT & SUPPLY, INC. These contractors provide critical medical devices, diagnostic services, and facility support solutions tailored to the unique logistical and cultural needs of tribal health centers. The procurement patterns reflect a preference for vendors with demonstrated experience in rural healthcare delivery and compliance with Indian Health Service standards, fostering long-term, mission-aligned partnerships. Miyasato’s contracting portfolio is evenly split between open competition and Buy Indian Set-Aside procurements, reflecting a strong institutional commitment to leveraging the Indian Self-Determination and Education Assistance Act. This preference prioritizes Native-owned businesses and tribally controlled organizations, reinforcing economic self-sufficiency within the communities served. While no other socioeconomic set-asides dominate, the consistent use of the Buy Indian authority underscores a deliberate strategy to advance tribal sovereignty through procurement. The agency’s primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 621512 (Diagnostic Imaging Centers), indicating deep expertise in acquiring advanced clinical diagnostics, laboratory testing systems, and imaging technologies. Miyasato’s technical acumen ensures that acquisitions meet stringent federal medical device regulations and are compatible with existing tribal health IT ecosystems, supporting accurate, timely, and culturally appropriate patient care.